These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10498195)

  • 21. Computer-aided design and synthesis of 5-substituted tryptamines and their pharmacology at the 5-HT1D receptor: discovery of compounds with potential anti-migraine properties.
    Glen RC; Martin GR; Hill AP; Hyde RM; Woollard PM; Salmon JA; Buckingham J; Robertson AD
    J Med Chem; 1995 Sep; 38(18):3566-80. PubMed ID: 7658443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of human 5-HT4(d) receptor desensitization in CHO cells.
    Mialet J; Fischmeister R; Lezoualc'h F
    Br J Pharmacol; 2003 Feb; 138(3):445-52. PubMed ID: 12569069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea-pig.
    Roberts C; Price GW; Gaster L; Jones BJ; Middlemiss DN; Routledge C
    Neuropharmacology; 1997; 36(4-5):549-57. PubMed ID: 9225280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.
    Valentin JP; Bonnafous R; John GW
    Br J Pharmacol; 1996 Sep; 119(1):35-42. PubMed ID: 8872354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivo.
    Millan MJ; Gobert A; Audinot V; Dekeyne A; Newman-Tancredi A
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):61S-67S. PubMed ID: 10432490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.
    Doménech T; Beleta J; Palacios JM
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):328-34. PubMed ID: 9303569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-(1-Naphthyloxy)ethylamines with enhanced affinity for human 5-HT1D beta (h5-HT1B) serotonin receptors.
    Ismaiel AM; Dukat M; Law H; Kamboj R; Fan E; Lee DK; Mazzocco L; Buekschkens D; Teitler M; Pierson ME; Glennon RA
    J Med Chem; 1997 Dec; 40(26):4415-9. PubMed ID: 9435911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype.
    Castro JL; Street LJ; Guiblin AR; Jelley RA; Russell MG; Sternfeld F; Beer MS; Stanton JA; Matassa VG
    J Med Chem; 1997 Oct; 40(22):3497-500. PubMed ID: 9357514
    [No Abstract]   [Full Text] [Related]  

  • 29. Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin(1A) receptors.
    Shannon HE; Lutz EA
    Psychopharmacology (Berl); 2000 Mar; 149(1):93-7. PubMed ID: 10789888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imipramine but not 5-HT(1A) receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT(1A) and 5-HT(4) receptors.
    Zahorodna A; Tokarski K; Bijak M
    Eur J Pharmacol; 2002 May; 443(1-3):51-7. PubMed ID: 12044792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.
    Glennon RA; Lee M; Rangisetty JB; Dukat M; Roth BL; Savage JE; McBride A; Rauser L; Hufeisen S; Lee DK
    J Med Chem; 2000 Mar; 43(5):1011-8. PubMed ID: 10715164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
    Schlicker E; Fink K; Molderings GJ; Price GW; Duckworth M; Gaster L; Middlemiss DN; Zentner J; Likungu J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):321-7. PubMed ID: 9303568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of [14C]guanidinium accumulation in NG 108-15 cells exposed to serotonin 5-HT3 receptor ligands and substance P.
    Emerit MB; Riad M; Fattaccini CM; Hamon M
    J Neurochem; 1993 Jun; 60(6):2059-67. PubMed ID: 7684066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT inhibits spontaneous contractility of isolated sheep mesenteric lymphatics via activation of 5-HT(4) receptors.
    McHale NG; Thornbury KD; Hollywood MA
    Microvasc Res; 2000 Nov; 60(3):261-8. PubMed ID: 11078642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further investigation into the signal transduction mechanism of the 5-HT4-like receptor in the circular smooth muscle of human colon.
    McLean PG; Coupar IM
    Br J Pharmacol; 1996 Jun; 118(4):1058-64. PubMed ID: 8799582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-Aza-6,8-dioxabicyclo[3.2.1]octanes as new enantiopure heteroatom-rich tropane-like ligands of human dopamine transporter.
    Cini N; Danieli E; Menchi G; Trabocchi A; Bottoncetti A; Raspanti S; Pupi A; Guarna A
    Bioorg Med Chem; 2006 Aug; 14(15):5110-20. PubMed ID: 16678430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation.
    Jandu KS; Barrett V; Brockwell M; Cambridge D; Farrant DR; Foster C; Giles H; Glen RC; Hill AP; Hobbs H; Honey A; Martin GR; Salmon J; Smith D; Woollard P; Selwood DL
    J Med Chem; 2001 Mar; 44(5):681-93. PubMed ID: 11262079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity.
    Selkirk JV; Scott C; Ho M; Burton MJ; Watson J; Gaster LM; Collin L; Jones BJ; Middlemiss DN; Price GW
    Br J Pharmacol; 1998 Sep; 125(1):202-8. PubMed ID: 9776361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.